Transcript 9833007
工工9833007吳秉承 The last place you’d probably expect to see a rapid respond team is at a production facility in Ciudad Juarez, Mexico. But that’s exactly what you’d find at the Cordis de Mexico S.A de C.V. facility that manufactures cardiovascular and endovascular devices. Employees at this facility- which is part of Cordis Corporation, a subsidiary of the medical-products maker Johnson&Johnson-make catheters and stents used to treat various circulatory system problems. The rapid response team is an employee troubleshooting group that’s called into action with Mozart’s Symphony No.40 blaring through the overhead speakers. Whenever a production-line employee activates the music to signal a problem on the line, the team races toward the work area to find out what’s happened and how it can be corrected quickly. Because customer demand is so great and the product manufacture so exacting, such work stoppages must be addressed promptly. Cordis plant managers want to make sure that the rapid response team gets the information it needs to do its job as quickly as possible. What would you do ? Cordis Corporation, a Johnson & Johnson company, is a worldwide leader in the development and manufacture of interventional vascular technology. Through the company's innovation, research and development, Cordis partners with interventional cardiologists worldwide to treat millions of patients who suffer from vascular disease. More information about Cordis Corporation can be found at www.cordis.com. *Cordis Corporation has entered into an exclusive worldwide license with Wyeth for the localized delivery of sirolimus in certain fields of use, including delivery via vascular stenting. Sirolimus, the active drug released for the stent, is marketed by Wyeth Pharmaceuticals, a division of Wyeth, under the name Rapamune®. Rapamune is a trademark of Wyeth Pharmaceuticals For 50 years, Cordis Corporation, a Johnson & Johnson company, has pioneered less invasive treatments for vascular disease. Technological innovation and a deep understanding of the medical marketplace and the needs of patients have made Cordis the world's leading developer and manufacturer of breakthrough stents, catheters and guidewires for interventional medicine, minimally invasive computer-based imaging, and electrophysiology. Today, approximately 5,000 Cordis employees worldwide share a strong commitment to continue the Company's groundbreaking work in the fight against vascular disease. Cordis is focused in five distinct areas: Cordis Cardiology for cardiovascular disease management; Cordis Endovascular for the treatment of peripheral vascular and biliary obstructive diseases; Conor Medsystems LLC for controlled vascular drug delivery technologies; Biosense Webster, Inc. for electrophysiology and medical sensor technology in cardiovascular procedures; and Cordis Biologics Delivery Systems Group in the emerging field of biologics delivery. 1.授權生產線員工 讓他們在回應團隊到達前，可以精確轉述必要的資訊 2.事前準備及了解 回應團隊須對生產線的每一站，有事前的基本了解， 面對問題狀況時，才可以有效率地解決問題。 3.改善資源品質 提高硬體、軟體的品質，以減少因為資源品質造成的問題，進 而提高效率。 4.實際上機前的訓練 員工需要接受問題基本解決技術和術語使用，以方便轉述快速 回應團隊。 5.分配功能區塊 團隊應有不同功能的工作分配，將生產站的每一點都列入功能 區塊。 http://www.jnj.com/connect/?flash=true http://www.cordis.com/ MANAGEMENT